These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12785872)

  • 1. Rapid hepatitis B immunisation for the traveller: comparison of two accelerated schedules with a 2-month schedule.
    Bock HL
    BioDrugs; 2003; 17 Suppl 1():11-3. PubMed ID: 12785872
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
    Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R
    BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
    Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated vaccination schedules provide protection against hepatitis A and B in last-minute travelers.
    Nothdurft HD; Zuckerman J; Stoffel M; Dieussaert I; Van Damme P
    J Travel Med; 2004; 11(4):260-1. PubMed ID: 15541232
    [No Abstract]   [Full Text] [Related]  

  • 5. A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedules.
    Marchou B; Excler JL; Bourderioux C; Salaun J; Picot N; Yvonnet B; Cerisier JE; Salomon H; Auvergnat JC
    J Infect Dis; 1995 Jul; 172(1):258-60. PubMed ID: 7797926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials.
    Jin H; Tan Z; Zhang X; Wang B; Zhao Y; Liu P
    PLoS One; 2015; 10(7):e0133464. PubMed ID: 26196903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The place of accelerated schedules for hepatitis A and B vaccinations.
    Zuckerman J
    Drugs; 2003; 63(17):1779-84. PubMed ID: 12921484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
    Proell S
    BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
    [No Abstract]   [Full Text] [Related]  

  • 9. [The immunological effectiveness and reactogenicity of the vaccine "HEP-A+B-in-VAC" against hepatitis A and B].
    Chuĭkova KI; Gordetskaia EL; Gorbunov MA; Maĭdaniuk AG; Pomytkina MI
    Vopr Virusol; 2006; 51(1):31-3. PubMed ID: 16515040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of hepatitis B vaccination on seronegative adults with different vaccination schedules.
    Yao J; Li J; Chen Y; Shan H; Dai XW; Yang LN; Jiang ZG; Ren JJ; Xu KJ; Ruan B; Yang SG; Wang B; Xie TS; Li Q
    Hum Vaccin Immunother; 2015; 11(5):1102-7. PubMed ID: 25621975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intradermal hepatitis B vaccination in workers not responsive to intramuscular vaccination].
    Bauer H; Potasman I; Pick N
    Harefuah; 1998 Mar; 134(6):441-4, 503. PubMed ID: 10909572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting on hepatitis B seroprotection in hemodialysis patients.
    Malaki M
    Saudi J Kidney Dis Transpl; 2017; 28(3):672-674. PubMed ID: 28540917
    [No Abstract]   [Full Text] [Related]  

  • 15. Intradermal hepatitis B vaccination: five-year follow-up.
    Leonardi S; Barone P; Musumeci S
    Pediatr Infect Dis J; 1995 Aug; 14(8):716-7. PubMed ID: 8532435
    [No Abstract]   [Full Text] [Related]  

  • 16. Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance.
    Van Herck K; Leuridan E; Van Damme P
    Sex Transm Infect; 2007 Oct; 83(6):426-32. PubMed ID: 17911142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with hepatitis B vaccine response among dentists.
    Cleveland JL; Siew C; Lockwood SA; Gruninger SE; Chang SB; Neidle EA; Russell CM
    J Dent Res; 1994 May; 73(5):1029-35. PubMed ID: 8006228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
    Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B vaccination in young nurses of a general hospital.
    Barone P; Sciacca A; Lupo F; Leonardi S; Musumeci S
    Ann Ig; 1995; 7(4):251-5. PubMed ID: 8679165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.